Community post

Stephanie Lynch (University of Sydney) and colleagues published the results of a survey on clinical needs and attitudes towards phage therapy among the cystic fibrosis community. The study highlights a significant reliance on antibiotics among CF patients, 62% awareness of phage therapy, and 96% interest in participating in phage therapy trials.